Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase 2 Study of the MEK inhibitor Trametinib (IND #119346, NSC# 763093) in Children with Relapsed or Refractory Juvenile Myelomonocytic Leukemia.

Multiple Cancer Types

Pediatric Leukemia, Pediatrics
II
Borinstein, Scott
NCT03190915
COGADVL1521

A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma.

Sarcoma

Sarcoma
II
Keedy, Vicki
NCT04044768
VICCSAR1948

Identifying Predictors of Poor Health-Related Quality-of-Life among Pediatric Hematopoietic Stem Cell Donors.

Pediatrics

Pediatrics
N/A
Kitko, Carrie
NCT03718546
VICCPED1949


AURORA US: Prospective Biospecimen Repository in Metastatic Breast Cancer

Breast

Breast
N/A
Park, Ben
NCT03737695
VICCBRE1954


A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab with or without Eflornithine (DFMO) (IND# 141913) in Children with Relapsed, Refractory or Progressive Neuroblastoma.

Multiple Cancer Types

Neuroblastoma (Pediatrics), Pediatrics
II
Benedetti, Daniel
NCT03794349
COGANBL1821

Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML).

Leukemia

Leukemia
II
Kishtagari, Ashwin
NCT03836209
VICCHEM1957

Prospective, Randomized, Crossover Trial Comparing Recombinant von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with von Willebrand Disease: The VWD Minimize Study

Multiple Cancer Types

Gynecologic, Hematologic
III
Wheeler, Allison
NCT02606045
VICCNCBH1961

To learn more about any of our clinical
trials, call 615-936-8422.